WEBVTT
Kind: captions
Language: pt

00:00:00.000 --> 00:00:03.139 align:start position:0%
 
em um<00:00:00.870><c> estudo</c><00:00:01.350><c> científico</c><00:00:01.970><c> apoiado</c><00:00:02.970><c> pelo</c>

00:00:03.139 --> 00:00:03.149 align:start position:0%
em um estudo científico apoiado pelo
 

00:00:03.149 --> 00:00:04.990 align:start position:0%
em um estudo científico apoiado pelo
Ministério<00:00:03.240><c> da</c><00:00:03.870><c> Ciência</c><00:00:04.049><c> Tecnologia</c>

00:00:04.990 --> 00:00:05.000 align:start position:0%
Ministério da Ciência Tecnologia
 

00:00:05.000 --> 00:00:08.120 align:start position:0%
Ministério da Ciência Tecnologia
inovações<00:00:06.290><c> comprovou</c><00:00:07.290><c> que</c><00:00:07.529><c> uso</c><00:00:08.010><c> da</c>

00:00:08.120 --> 00:00:08.130 align:start position:0%
inovações comprovou que uso da
 

00:00:08.130 --> 00:00:11.330 align:start position:0%
inovações comprovou que uso da
nitazoxanida<00:00:09.030><c> é</c><00:00:09.660><c> capaz</c><00:00:10.139><c> de</c><00:00:10.260><c> reduzir</c><00:00:10.500><c> a</c><00:00:10.950><c> carga</c>

00:00:11.330 --> 00:00:11.340 align:start position:0%
nitazoxanida é capaz de reduzir a carga
 

00:00:11.340 --> 00:00:14.419 align:start position:0%
nitazoxanida é capaz de reduzir a carga
viral<00:00:11.490><c> de</c><00:00:11.880><c> pacientes</c><00:00:12.170><c> com</c><00:00:13.170><c> sintomas</c><00:00:13.830><c> iniciais</c>

00:00:14.419 --> 00:00:14.429 align:start position:0%
viral de pacientes com sintomas iniciais
 

00:00:14.429 --> 00:00:18.170 align:start position:0%
viral de pacientes com sintomas iniciais
de<00:00:14.719><c> covid-19</c><00:00:15.830><c> por</c><00:00:16.830><c> isso</c><00:00:17.250><c> o</c><00:00:17.490><c> antiviral</c>

00:00:18.170 --> 00:00:18.180 align:start position:0%
de covid-19 por isso o antiviral
 

00:00:18.180 --> 00:00:20.710 align:start position:0%
de covid-19 por isso o antiviral
nitazoxanida<00:00:19.080><c> se</c><00:00:19.920><c> tornou</c><00:00:20.279><c> uma</c><00:00:20.310><c> alternativa</c>

00:00:20.710 --> 00:00:20.720 align:start position:0%
nitazoxanida se tornou uma alternativa
 

00:00:20.720 --> 00:00:24.529 align:start position:0%
nitazoxanida se tornou uma alternativa
eficaz<00:00:21.980><c> segura</c><00:00:22.980><c> e</c><00:00:23.310><c> barata</c><00:00:23.550><c> na</c><00:00:24.060><c> luta</c><00:00:24.480><c> diária</c>

00:00:24.529 --> 00:00:24.539 align:start position:0%
eficaz segura e barata na luta diária
 

00:00:24.539 --> 00:00:28.599 align:start position:0%
eficaz segura e barata na luta diária
que<00:00:25.350><c> o</c><00:00:25.439><c> Brasil</c><00:00:25.859><c> trava</c><00:00:26.490><c> contra</c><00:00:27.119><c> o</c><00:00:27.240><c> coronavírus</c>

00:00:28.599 --> 00:00:28.609 align:start position:0%
que o Brasil trava contra o coronavírus
 

00:00:28.609 --> 00:00:32.630 align:start position:0%
que o Brasil trava contra o coronavírus
você<00:00:29.660><c> profissional</c><00:00:30.660><c> de</c><00:00:30.779><c> saúde</c><00:00:31.189><c> sabe</c><00:00:32.189><c> melhor</c>

00:00:32.630 --> 00:00:32.640 align:start position:0%
você profissional de saúde sabe melhor
 

00:00:32.640 --> 00:00:35.000 align:start position:0%
você profissional de saúde sabe melhor
do<00:00:32.730><c> que</c><00:00:32.850><c> ninguém</c><00:00:33.120><c> que</c><00:00:33.719><c> o</c><00:00:33.930><c> nosso</c><00:00:34.290><c> país</c><00:00:34.559><c> que</c><00:00:34.829><c> está</c>

00:00:35.000 --> 00:00:35.010 align:start position:0%
do que ninguém que o nosso país que está
 

00:00:35.010 --> 00:00:37.010 align:start position:0%
do que ninguém que o nosso país que está
travando<00:00:35.280><c> uma</c><00:00:35.550><c> guerra</c><00:00:35.700><c> contra</c><00:00:36.180><c> o</c><00:00:36.570><c> coronavírus</c>

00:00:37.010 --> 00:00:37.020 align:start position:0%
travando uma guerra contra o coronavírus
 

00:00:37.020 --> 00:00:41.360 align:start position:0%
travando uma guerra contra o coronavírus
e<00:00:37.890><c> um</c><00:00:38.070><c> dos</c><00:00:38.340><c> nossos</c><00:00:38.670><c> adversários</c><00:00:38.940><c> é</c><00:00:39.840><c> o</c><00:00:39.989><c> tempo</c><00:00:40.410><c> os</c>

00:00:41.360 --> 00:00:41.370 align:start position:0%
e um dos nossos adversários é o tempo os
 

00:00:41.370 --> 00:00:43.880 align:start position:0%
e um dos nossos adversários é o tempo os
cientistas<00:00:41.430><c> e</c><00:00:42.329><c> os</c><00:00:42.480><c> órgãos</c><00:00:42.809><c> de</c><00:00:43.050><c> inteligências</c>

00:00:43.880 --> 00:00:43.890 align:start position:0%
cientistas e os órgãos de inteligências
 

00:00:43.890 --> 00:00:46.810 align:start position:0%
cientistas e os órgãos de inteligências
federais<00:00:44.610><c> não</c><00:00:45.149><c> estão</c><00:00:45.629><c> medindo</c><00:00:45.840><c> esforços</c><00:00:46.079><c> para</c>

00:00:46.810 --> 00:00:46.820 align:start position:0%
federais não estão medindo esforços para
 

00:00:46.820 --> 00:00:50.209 align:start position:0%
federais não estão medindo esforços para
combater<00:00:47.820><c> essa</c><00:00:47.969><c> ameaça</c><00:00:48.539><c> a</c><00:00:49.289><c> pesquisa</c><00:00:49.980><c> foi</c>

00:00:50.209 --> 00:00:50.219 align:start position:0%
combater essa ameaça a pesquisa foi
 

00:00:50.219 --> 00:00:52.490 align:start position:0%
combater essa ameaça a pesquisa foi
iniciada<00:00:50.309><c> pelo</c><00:00:51.180><c> laboratório</c><00:00:51.600><c> Nacional</c><00:00:52.020><c> de</c>

00:00:52.490 --> 00:00:52.500 align:start position:0%
iniciada pelo laboratório Nacional de
 

00:00:52.500 --> 00:00:55.340 align:start position:0%
iniciada pelo laboratório Nacional de
biociências<00:00:52.850><c> em</c><00:00:53.850><c> Campinas</c><00:00:54.570><c> órgão</c><00:00:55.199><c> que</c>

00:00:55.340 --> 00:00:55.350 align:start position:0%
biociências em Campinas órgão que
 

00:00:55.350 --> 00:00:58.250 align:start position:0%
biociências em Campinas órgão que
integra<00:00:55.860><c> o</c><00:00:55.980><c> centro</c><00:00:56.280><c> Nacional</c><00:00:56.699><c> de</c><00:00:57.239><c> pesquisa</c><00:00:57.989><c> em</c>

00:00:58.250 --> 00:00:58.260 align:start position:0%
integra o centro Nacional de pesquisa em
 

00:00:58.260 --> 00:01:00.000 align:start position:0%
integra o centro Nacional de pesquisa em
energia<00:00:58.379><c> e</c><00:00:59.070><c> materiais</c>

00:01:00.000 --> 00:01:00.010 align:start position:0%
energia e materiais
 

00:01:00.010 --> 00:01:01.799 align:start position:0%
energia e materiais
o lado<00:01:00.850><c> o</c><00:01:00.940><c> ministério</c><00:01:01.570><c> da</c><00:01:01.660><c> Ciência</c>

00:01:01.799 --> 00:01:01.809 align:start position:0%
o lado o ministério da Ciência
 

00:01:01.809 --> 00:01:06.390 align:start position:0%
o lado o ministério da Ciência
Tecnologia<00:01:03.269><c> inovações</c><00:01:04.379><c> após</c><00:01:05.379><c> esse</c><00:01:05.560><c> teste</c><00:01:05.770><c> o</c>

00:01:06.390 --> 00:01:06.400 align:start position:0%
Tecnologia inovações após esse teste o
 

00:01:06.400 --> 00:01:11.310 align:start position:0%
Tecnologia inovações após esse teste o
fármaco<00:01:07.150><c> nitazoxanida</c><00:01:08.520><c> apresentou</c><00:01:09.720><c> 94%</c><00:01:10.720><c> de</c>

00:01:11.310 --> 00:01:11.320 align:start position:0%
fármaco nitazoxanida apresentou 94% de
 

00:01:11.320 --> 00:01:17.510 align:start position:0%
fármaco nitazoxanida apresentou 94% de
capacidade<00:01:12.310><c> de</c><00:01:12.520><c> inibir</c><00:01:13.270><c> o</c><00:01:13.479><c> novo</c><00:01:14.080><c> coronavírus</c>

00:01:17.510 --> 00:01:17.520 align:start position:0%
 
 

00:01:17.520 --> 00:01:20.399 align:start position:0%
 
nitazoxanida<00:01:18.520><c> foi</c><00:01:19.030><c> o</c><00:01:19.149><c> fármaco</c><00:01:19.780><c> com</c><00:01:19.899><c> melhor</c>

00:01:20.399 --> 00:01:20.409 align:start position:0%
nitazoxanida foi o fármaco com melhor
 

00:01:20.409 --> 00:01:22.859 align:start position:0%
nitazoxanida foi o fármaco com melhor
desempenho<00:01:20.830><c> nesse</c><00:01:21.549><c> objetivo</c><00:01:21.970><c> mas</c><00:01:22.600><c> era</c>

00:01:22.859 --> 00:01:22.869 align:start position:0%
desempenho nesse objetivo mas era
 

00:01:22.869 --> 00:01:25.560 align:start position:0%
desempenho nesse objetivo mas era
necessário<00:01:22.990><c> saber</c><00:01:23.920><c> o</c><00:01:24.159><c> fármaco</c><00:01:24.850><c> teria</c><00:01:25.180><c> o</c><00:01:25.240><c> mesmo</c>

00:01:25.560 --> 00:01:25.570 align:start position:0%
necessário saber o fármaco teria o mesmo
 

00:01:25.570 --> 00:01:28.560 align:start position:0%
necessário saber o fármaco teria o mesmo
efeito<00:01:25.810><c> em</c><00:01:26.320><c> humanos</c><00:01:26.560><c> Após</c><00:01:27.340><c> a</c><00:01:27.729><c> aprovação</c><00:01:28.030><c> da</c>

00:01:28.560 --> 00:01:28.570 align:start position:0%
efeito em humanos Após a aprovação da
 

00:01:28.570 --> 00:01:32.190 align:start position:0%
efeito em humanos Após a aprovação da
conep<00:01:28.899><c> a</c><00:01:29.500><c> professora</c><00:01:30.250><c> Patrícia</c><00:01:30.460><c> Goku</c><00:01:31.360><c> iniciou</c>

00:01:32.190 --> 00:01:32.200 align:start position:0%
conep a professora Patrícia Goku iniciou
 

00:01:32.200 --> 00:01:33.450 align:start position:0%
conep a professora Patrícia Goku iniciou
o<00:01:32.229><c> estudo</c><00:01:32.500><c> Clínico</c><00:01:33.159><c> em</c><00:01:33.280><c> pacientes</c>

00:01:33.450 --> 00:01:33.460 align:start position:0%
o estudo Clínico em pacientes
 

00:01:33.460 --> 00:01:37.169 align:start position:0%
o estudo Clínico em pacientes
voluntários<00:01:34.179><c> com</c><00:01:34.990><c> o</c><00:01:35.310><c> covid-19</c><00:01:36.310><c> em</c><00:01:36.640><c> estágio</c>

00:01:37.169 --> 00:01:37.179 align:start position:0%
voluntários com o covid-19 em estágio
 

00:01:37.179 --> 00:01:40.649 align:start position:0%
voluntários com o covid-19 em estágio
precoce<00:01:37.420><c> da</c><00:01:37.960><c> doença</c><00:01:38.940><c> iniciamos</c><00:01:39.940><c> um</c><00:01:40.210><c> estudo</c>

00:01:40.649 --> 00:01:40.659 align:start position:0%
precoce da doença iniciamos um estudo
 

00:01:40.659 --> 00:01:44.280 align:start position:0%
precoce da doença iniciamos um estudo
Clínico<00:01:41.909><c> duplo</c><00:01:42.909><c> céu</c>

00:01:44.280 --> 00:01:44.290 align:start position:0%
Clínico duplo céu
 

00:01:44.290 --> 00:01:48.000 align:start position:0%
Clínico duplo céu
e<00:01:44.880><c> duplo-cego</c><00:01:45.880><c> significa</c><00:01:46.750><c> onde</c><00:01:47.650><c> nenhum</c>

00:01:48.000 --> 00:01:48.010 align:start position:0%
e duplo-cego significa onde nenhum
 

00:01:48.010 --> 00:01:51.560 align:start position:0%
e duplo-cego significa onde nenhum
paciente<00:01:48.660><c> nenhum</c><00:01:49.660><c> médico</c><00:01:50.400><c> tinha</c>

00:01:51.560 --> 00:01:51.570 align:start position:0%
paciente nenhum médico tinha
 

00:01:51.570 --> 00:01:54.030 align:start position:0%
paciente nenhum médico tinha
conhecimento<00:01:52.570><c> da</c><00:01:52.720><c> medicação</c><00:01:53.410><c> que</c><00:01:53.620><c> estava</c>

00:01:54.030 --> 00:01:54.040 align:start position:0%
conhecimento da medicação que estava
 

00:01:54.040 --> 00:01:58.800 align:start position:0%
conhecimento da medicação que estava
sendo<00:01:54.400><c> utilizar</c><00:01:56.520><c> randomizado</c><00:01:57.690><c> onde</c><00:01:58.690><c> os</c>

00:01:58.800 --> 00:01:58.810 align:start position:0%
sendo utilizar randomizado onde os
 

00:01:58.810 --> 00:02:02.000 align:start position:0%
sendo utilizar randomizado onde os
pacientes<00:01:59.290><c> eram</c><00:01:59.770><c> divididos</c><00:02:00.750><c> aleatoriamente</c>

00:02:02.000 --> 00:02:02.010 align:start position:0%
pacientes eram divididos aleatoriamente
 

00:02:02.010 --> 00:02:06.690 align:start position:0%
pacientes eram divididos aleatoriamente
em<00:02:03.010><c> dois</c><00:02:03.160><c> grupos</c><00:02:03.780><c> um</c><00:02:04.780><c> grupo</c><00:02:05.160><c> que</c><00:02:06.160><c> recebeu</c>

00:02:06.690 --> 00:02:06.700 align:start position:0%
em dois grupos um grupo que recebeu
 

00:02:06.700 --> 00:02:10.320 align:start position:0%
em dois grupos um grupo que recebeu
nitazoxanida<00:02:07.619><c> e</c><00:02:08.619><c> um</c><00:02:08.740><c> grupo</c><00:02:09.009><c> que</c><00:02:09.850><c> recebeu</c>

00:02:10.320 --> 00:02:10.330 align:start position:0%
nitazoxanida e um grupo que recebeu
 

00:02:10.330 --> 00:02:11.840 align:start position:0%
nitazoxanida e um grupo que recebeu
placebo

00:02:11.840 --> 00:02:11.850 align:start position:0%
placebo
 

00:02:11.850 --> 00:02:15.770 align:start position:0%
placebo
e eu<00:02:12.710><c> submetemos</c><00:02:13.710><c> a</c><00:02:14.070><c> comissão</c><00:02:14.850><c> nacional</c><00:02:15.120><c> de</c>

00:02:15.770 --> 00:02:15.780 align:start position:0%
e eu submetemos a comissão nacional de
 

00:02:15.780 --> 00:02:18.620 align:start position:0%
e eu submetemos a comissão nacional de
ética<00:02:15.990><c> em</c><00:02:16.350><c> pesquisa</c><00:02:17.040><c> o</c><00:02:17.520><c> conner</c>

00:02:18.620 --> 00:02:18.630 align:start position:0%
ética em pesquisa o conner
 

00:02:18.630 --> 00:02:22.640 align:start position:0%
ética em pesquisa o conner
o e<00:02:19.350><c> posteriormente</c><00:02:20.240><c> ao</c><00:02:21.240><c> comitê</c><00:02:21.750><c> de</c><00:02:22.020><c> ética</c><00:02:22.200><c> em</c>

00:02:22.640 --> 00:02:22.650 align:start position:0%
o e posteriormente ao comitê de ética em
 

00:02:22.650 --> 00:02:25.750 align:start position:0%
o e posteriormente ao comitê de ética em
pesquisa<00:02:23.370><c> de</c><00:02:23.760><c> cada</c><00:02:24.300><c> unidade</c><00:02:24.660><c> hospitalar</c>

00:02:25.750 --> 00:02:25.760 align:start position:0%
pesquisa de cada unidade hospitalar
 

00:02:25.760 --> 00:02:28.640 align:start position:0%
pesquisa de cada unidade hospitalar
esses<00:02:26.760><c> pacientes</c><00:02:27.420><c> eram</c><00:02:27.600><c> acompanhados</c><00:02:28.470><c> de</c>

00:02:28.640 --> 00:02:28.650 align:start position:0%
esses pacientes eram acompanhados de
 

00:02:28.650 --> 00:02:31.960 align:start position:0%
esses pacientes eram acompanhados de
forma<00:02:29.010><c> remota</c><00:02:29.370><c> até</c><00:02:30.150><c> 7</c><00:02:30.720><c> dias</c><00:02:30.840><c> após</c><00:02:31.350><c> a</c><00:02:31.590><c> terapia</c>

00:02:31.960 --> 00:02:31.970 align:start position:0%
forma remota até 7 dias após a terapia
 

00:02:31.970 --> 00:02:35.540 align:start position:0%
forma remota até 7 dias após a terapia
sendo<00:02:32.970><c> constatado</c><00:02:33.900><c> que</c><00:02:34.170><c> a</c><00:02:34.260><c> nitazoxanida</c><00:02:34.560><c> em</c>

00:02:35.540 --> 00:02:35.550 align:start position:0%
sendo constatado que a nitazoxanida em
 

00:02:35.550 --> 00:02:38.810 align:start position:0%
sendo constatado que a nitazoxanida em
comparação<00:02:36.300><c> com</c><00:02:36.600><c> o</c><00:02:36.630><c> Placebo</c><00:02:37.160><c> causou</c><00:02:38.160><c> ao</c><00:02:38.460><c> final</c>

00:02:38.810 --> 00:02:38.820 align:start position:0%
comparação com o Placebo causou ao final
 

00:02:38.820 --> 00:02:41.900 align:start position:0%
comparação com o Placebo causou ao final
da<00:02:38.940><c> terapia</c><00:02:39.540><c> uma</c><00:02:39.990><c> redução</c><00:02:40.380><c> significativa</c><00:02:41.310><c> da</c>

00:02:41.900 --> 00:02:41.910 align:start position:0%
da terapia uma redução significativa da
 

00:02:41.910 --> 00:02:44.330 align:start position:0%
da terapia uma redução significativa da
Carga<00:02:42.120><c> viral</c><00:02:42.510><c> tendo</c><00:02:43.080><c> mais</c><00:02:43.470><c> pacientes</c><00:02:44.190><c> com</c><00:02:44.310><c> o</c>

00:02:44.330 --> 00:02:44.340 align:start position:0%
Carga viral tendo mais pacientes com o
 

00:02:44.340 --> 00:02:48.310 align:start position:0%
Carga viral tendo mais pacientes com o
resultado<00:02:44.730><c> negativo</c><00:02:45.210><c> para</c><00:02:46.050><c> os</c><00:02:46.260><c> ares</c><00:02:46.650><c> cov2</c>

00:02:48.310 --> 00:02:48.320 align:start position:0%
resultado negativo para os ares cov2
 

00:02:48.320 --> 00:02:51.560 align:start position:0%
resultado negativo para os ares cov2
hoje<00:02:49.320><c> o</c><00:02:49.410><c> Brasil</c><00:02:49.890><c> tem</c><00:02:50.040><c> um</c><00:02:50.280><c> medicamento</c><00:02:50.580><c> capaz</c>

00:02:51.560 --> 00:02:51.570 align:start position:0%
hoje o Brasil tem um medicamento capaz
 

00:02:51.570 --> 00:02:54.170 align:start position:0%
hoje o Brasil tem um medicamento capaz
de<00:02:51.630><c> reduzir</c><00:02:52.320><c> a</c><00:02:52.380><c> carga</c><00:02:52.650><c> viral</c><00:02:52.800><c> que</c><00:02:53.430><c> diminui</c><00:02:54.060><c> a</c>

00:02:54.170 --> 00:02:54.180 align:start position:0%
de reduzir a carga viral que diminui a
 

00:02:54.180 --> 00:02:56.150 align:start position:0%
de reduzir a carga viral que diminui a
probabilidade<00:02:54.570><c> de</c><00:02:55.170><c> agravamento</c><00:02:55.620><c> dos</c>

00:02:56.150 --> 00:02:56.160 align:start position:0%
probabilidade de agravamento dos
 

00:02:56.160 --> 00:02:58.460 align:start position:0%
probabilidade de agravamento dos
sintomas<00:02:56.630><c> reduza</c><00:02:57.630><c> o</c><00:02:57.660><c> Contagem</c><00:02:58.200><c> entre</c><00:02:58.380><c> as</c>

00:02:58.460 --> 00:02:58.470 align:start position:0%
sintomas reduza o Contagem entre as
 

00:02:58.470 --> 00:03:02.230 align:start position:0%
sintomas reduza o Contagem entre as
pessoas<00:02:59.130><c> E</c><00:02:59.310><c> é</c><00:02:59.520><c> comprovado</c><00:03:01.040><c> científicamente</c>

00:03:02.230 --> 00:03:02.240 align:start position:0%
pessoas E é comprovado científicamente
 

00:03:02.240 --> 00:03:06.560 align:start position:0%
pessoas E é comprovado científicamente
Anitta<00:03:03.240><c> zoxamida</c><00:03:03.690><c> vai</c><00:03:04.560><c> ajudar</c><00:03:05.160><c> todos</c><00:03:05.700><c> nós</c><00:03:06.180><c> a</c>

00:03:06.560 --> 00:03:06.570 align:start position:0%
Anitta zoxamida vai ajudar todos nós a
 

00:03:06.570 --> 00:03:14.320 align:start position:0%
Anitta zoxamida vai ajudar todos nós a
vencer<00:03:07.170><c> o</c><00:03:07.290><c> coronavírus</c>

00:03:14.320 --> 00:03:14.330 align:start position:0%
 
 

00:03:14.330 --> 00:03:16.390 align:start position:0%
 
E aí

